Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer

Oncogene

Volumn 31, Issue 8, 2012, Pages 1034-1044

  Kim, K ^a   Chadalapaka, G ^b   Lee, S O ^a   Yamada, D ^c   Sastre Garau, X ^d   Defossez, P A ^c   Park, Y Y ^a   Lee, J S ^a   Safe, S ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Université Sorbonne Paris Cité   (France)

^d INSTITUT CURIE   (France)

Author keywords

breast cancer; miR 17 92 cluster; prognostic; Sp transcription factors; ZBTB4

Indexed keywords

MICRORNA; MIR 106A; MIR 106B; MIR 175P; MIR 20A; MIR 93; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR SP4; UNCLASSIFIED DRUG; ZINC FINGER AND BTB DOMAIN CONTAINING 4 PROTEIN; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BINDING, COMPETITIVE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE-FREE SURVIVAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; KAPLAN-MEIER ESTIMATE; LUCIFERASES; MICRORNAS; ONCOGENES; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; RNA INTERFERENCE; SP TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84857355139     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.296     Document Type: Article

References (47)

1. Abdelrahim M, Baker CH, Abbruzzese JL, Sheikh-Hamad D, Liu S, Cho SD et al. (2007). Regulation of vascular endothelial growth factor receptor-1 (VEGFR1) expression by specificity proteins 1, 3 and 4 in pancreatic cancer cells. Cancer Res 67: 3286-3294. (Pubitemid 46724867)
2. Abdelrahim M, Samudio I, Smith R, Burghardt R, Safe S. (2002). Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 277: 28815-28822.
3. Abdelrahim M, Smith III R, Burghardt R, Safe S. (2004). Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res 64: 6740-6749. (Pubitemid 39297937)
4. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ et al. (2007). MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8: R214.
5. Blower PE, Verducci JS, Lin S, Zhou J, Chung JH, Dai Z et al. (2007). MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 6: 1483-1491. (Pubitemid 46954015)
6. Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula SV, Shen Q et al. (2005). Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 7: 445-455. (Pubitemid 40719128)
7. Chadalapaka G, Jutooru I, Burghardt R, Safe S. (2010). Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells. Mol Cancer Res 8: 739-750.
8. Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith III R, Li X et al. (2008). Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 68: 5345-5354.
9. Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. (2005). Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123: 437-448. (Pubitemid 41546674)
10. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M et al. (2003). Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33: 197-202. (Pubitemid 36177074)
11. Costoya JA. (2007). Functional analysis of the role of POK transcriptional repressors. Brief Funct Genomic Proteomic 6: 8-18. (Pubitemid 351721044)
12. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al. (2006). Augmentation of tumor angiogenesis by a Mycactivated microRNA cluster. Nat Genet 38: 1060-1065. (Pubitemid 44325933)
13. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868. (Pubitemid 29003722)
14. Filion GJ, Zhenilo S, Salozhin S, Yamada D, Prokhortchouk E, Defossez PA. (2006). A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 26: 169-181.
15. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. (2008). Antagomir-17-5p abolishes the growth of therapyresistant neuroblastoma through p21 and BIM. PLoS One 3: e2236.
16. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
17. Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K. (2009). MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113: 396-402.
18. Jeon BN, Choi WI, Yu MY, Yoon AR, Kim MH, Yun CO et al. (2009). ZBTB2, a novel master regulator of the p53 pathway. J Biol Chem 284: 17935-17946.
19. Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW. (2008). Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283: 33199-33210.
20. Jutooru I, Chadalapaka G, Abdelrahim M, Basha MR, Samudio I, Konopleva M et al. (2010). Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate (CDDO-Me) decreases specificity protein (Sp) transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a. Mol Pharmacol 78: 226-236.
21. Koh DI, Choi WI, Jeon BN, Lee CE, Yun CO, Hur MW. (2009). A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. J Biol Chem 284: 19856-19866.
22. Kojima S, Hatano M, Okada S, Fukuda T, Toyama Y, Yuasa S et al. (2001). Testicular germ cell apoptosis in Bcl6-deficient mice. Development 128: 57-65. (Pubitemid 32094385)
23. Koutsodontis G, Moustakas A, Kardassis D. (2002). The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF 1/Cip1 gene promoter. Biochemistry 41: 12771-12784. (Pubitemid 35192506)
24. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37: 495-500. (Pubitemid 40617277)
25. Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K et al. (2010). Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res 70: 6824-6836.
26. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H et al. (2008). Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359: 2313-2323.
27. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. (2003). Prediction of mammalian microRNA targets. Cell 115: 787-798. (Pubitemid 38058492)
28. Li H, Bian C, Liao L, Li J, Zhao RC. (2011). miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat 126: 565-575.
29. Liu H, D'Andrade P, Fulmer-Smentek S, Lorenzi P, Kohn KW, Weinstein JN et al. (2010). mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities. Mol Cancer Ther 9: 1080-1091.
30. Liu S, Goldstein RH, Scepansky EM, Rosenblatt M. (2009). Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res 69: 8742-8751.
31. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C et al. (2005). Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433: 278-285.
32. Mertens-Talcott SU, Chintharlapalli S, Li X, Safe S. (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein (Sp) transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res 67: 11001-11011. (Pubitemid 350145930)
33. Nicolas M, Noe V, Jensen KB, Ciudad CJ. (2001). Cloning and characterization of the 50-flanking region of the human transcription factor Sp1 gene. J Biol Chem 276: 22126-22132.
34. Niu H. (2002). The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol Oncol 20: 155-166. (Pubitemid 36070075)
35. Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C et al. (2006). Estrogen-regulated genes predict survival in hormone receptorpositive breast cancers. J Clin Oncol 24: 1656-1664. (Pubitemid 46622136)
36. Pendergrast PS, Wang C, Hernandez N, Huang S. (2002). FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles. Mol Biol Cell 13: 915-929. (Pubitemid 34250355)
37. Perez-Torrado R, Yamada D, Defossez PA. (2006). Born to bind: the BTB protein-protein interaction domain. Bioessays 28: 1194-1202. (Pubitemid 44925439)
38. Sasai N, Nakao M, Defossez PA. (2010). Sequence-specific recognition of methylated DNA by human zinc-finger proteins. Nucleic Acids Res 38: 5015-5022.
39. Shankavaram UT, Reinhold WC, Nishizuka S, Major S, Morita D, Chary KK et al. (2007). Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol Cancer Ther 6: 820-832. (Pubitemid 46554552)
40. Takeuchi T, Tomida S, Yatabe Y, Kosaka T, Osada H, Yanagisawa K et al. (2006). Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 24: 1679-1688. (Pubitemid 46622139)
41. Tapias A, Ciudad CJ, Noe V. (2008). Transcriptional regulation of the 50-flanking region of the human transcription factor Sp3 gene by NF-1, c-Myb, B-Myb, AP-1 and E2F. Biochim Biophys Acta 1779: 318-329. (Pubitemid 351645141)
42. Tillotson LG. (1999). RIN ZF, a novel zinc finger gene, encodes proteins that bind to the CACC element of the gastrin promoter. J Biol Chem 274: 8123-8128.
43. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009. (Pubitemid 35461656)
44. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
45. Weber A, Marquardt J, Elzi D, Forster N, Starke S, Glaum A et al. (2008). Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation. EMBO J 27: 1563-1574. (Pubitemid 351794031)
46. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M et al. (2008). A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182: 509-517.
47. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y et al. (2010). microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107: 8231-8236.